Press release ICCI
Prague, 26th November 2019
Representatives from the International Cannabis and Cannabinoids Institute (ICCI) returned from a successful mission to Thailand, where an agreement was reached with the Dean of the Faculty of Pharmaceutical Sciences at Chulalongkorn University in Bangkok, to develop cooperative medical cannabis and cannabinoids research projects. Thailand has recently become the first country in Southeast Asia to legalize medical cannabis, and plans to make it available to patients in local hospitals.
Chulalongkorn University is looking forward to working with the ICCI to help optimize the quality and safety of the medical cannabis products that will be available to patients. Pavel Kubů, CEO and director of the institute adds: "The agreement with Chulalongkorn University is great news for the prestige of Czech science and for increasing the availability of medical cannabis to patients. The Thai government is first of its kind in East Asia, and we are very happy that Czech experts can help there. On the other hand, the energy and straightforwardness of Thai colleagues are very inspiring for us."
Additionally, during a face-to-face meeting in Bangkok, the contract was extended to include the exchange of postgraduate study programs.
Jindřich Vobořil, former National Anti-Drug Coordinator, who was directly responsible for drafting the 2013 law that made medical cannabis legal in the Czech Republic, and prepared the cooperative agreement for ICCI, added: "Medical cannabis is currently a major international topic. Both professional and economic, but also political. In the Czech Republic, we have the potential to be at the forefront of innovation in this area and I do not want to miss this opportunity. ICCI strives to realize this potential through this worldwide expertise."
Aleš Ždimera, Counsellour, and Head of the Economic Section of the Embassy of the Czech Republic in the Kingdom of Thailand, explained the importance of this cooperation: "It is very gratifying that Czech entities have not only responded and captured the new dynamic trend in Thailand, but also participated in its direction from an early stage."
The International Cannabis and Cannabinoids Institute, in cooperation with its Czech partners, offers a wide range of services within the expanse of its consulting, educational and research activities, and plays a leading role in all aspects of medical cannabis. In addition to working with regulators and investors, ICCI has successfully completed negotiations on a cooperative framework with the Faculty of Pharmaceutical Sciences of Chulalongkorn University, a leading Thai university, and signed a memorandum of cooperation with them. This agreement received support from the Chulalongkorn University Rector during his meeting with the Ambassador of the Czech Republic.
ICCI was created as a joint venture between patient organizations, scientific institutes, and the US investment company Dioscorides Global Holdings. Its headquarters is in Prague, and as the center of excellence in medical cannabis, it cooperates internationally with governments, universities and scientific institutions. ICCI has recently been involved in employing unique analytical methods for testing the quality of retail CBD products, which is of great interest and importance to consumers around the world.